OncoCyte Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
0.83
|
|
Average Rating
|
3.60
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.11
|
-0.08
|
0.03
|
27.27%
|
|
2022-06-30
|
-0.12
|
-0.07
|
0.05
|
41.67%
|
|
2022-03-31
|
-0.12
|
-0.11
|
0.01
|
8.33%
|
|
2021-12-31
|
-0.13
|
-0.12
|
0.01
|
7.69%
|
|
2021-09-30
|
-0.12
|
-0.15
|
-0.03
|
-25.00%
|
|
2021-06-30
|
-0.10
|
-0.12
|
-0.02
|
-20.00%
|
|
2021-03-31
|
-0.10
|
-0.05
|
0.05
|
50.00%
|
|
2020-12-31
|
-0.11
|
-0.09
|
0.02
|
18.18%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.26
|
|
2021-12-31
|
-0.44
|
|
2020-12-31
|
-0.46
|
|
2019-12-31
|
-0.45
|
|
2018-12-31
|
-0.43
|
|
2017-12-31
|
-0.64
|
|
2016-12-31
|
-0.43
|
|
2015-12-31
|
-0.14
|